Publikation

Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2.

Wissenschaftlicher Artikel/Review - 28.10.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Woelfel S, Dütschler J, König M, Graf N, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Wyss J, Krupka N, Albrich W, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Friedrich M, Misselwitz B, Korte W, Bürgi J, Brand S. Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2. Aliment Pharmacol Ther 2022; 57:103-116.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Aliment Pharmacol Ther 2022; 57
Veröffentlichungsdatum
28.10.2022
eISSN (Online)
1365-2036
Seiten
103-116
Kurzbeschreibung/Zielsetzung

Immunosuppressed patients with inflammatory bowel disease (IBD) experience increased risk of vaccine-preventable diseases such as COVID-19.